You are here
News
Genome British Columbia announces new Chief Executive Officer
Monday, April 18, 2016
Genome British Columbia (Genome BC) is pleased to announce the appointment of Pascal Spothelfer as President & Chief Executive Officer beginning Monday, June 6.
Dr. Spothelfer joins Genome BC with a wealth of business and commercialization experience with which to lead the organization into the next decade. In the current strategic plan 2015-2020, Genome BC lays the long-term foundation to grow genomics applications, translation and commercialization in BC.
Genome Canada applauds federal leadership in genomics
Tuesday, March 22, 2016
March 22, 2016, Ottawa, Ontario – Genome Canada was delighted with a new federal investment of $237.2 million in funding for genomics, announced as part of Budget 2016.
Minister Duncan announces new network to strengthen personalized medicine for Canadians
Thursday, March 17, 2016
March 17, 2016, Ottawa, Ontario – The Minister of Science, Kirsty Duncan, today launched a $2 million initiative designed to accelerate the translation of research results into practical applications in healthcare for the benefit of Canadians.
Science Minister Duncan announces support for new genomic application projects
Thursday, March 10, 2016
March 10, 2016, Ottawa, Ontario – A $4.2 million federal investment for four new projects that will use genomic technologies to drive innovation and commercialization across diverse sectors was announced today by Minister of Science, Kirsty Duncan.
New Cancer Stem Cell Dream Team to Fight Brain Cancer in Children and Adults
Thursday, February 4, 2016
Canada has a brand new team of researchers working to develop novel treatments for brain cancers in children and adults. Terry Beech, Parliamentary Secretary to the Minister of Science, was at the Hospital for Sick Children (SickKids) in Toronto today to announce that the Government of Canada is providing $10 million in funding to the Stand Up To Cancer Canada Cancer Stem Cell Dream Team.
Biology of tumour changes when childhood brain cancer recurs, Canadian study finds
Wednesday, January 13, 2016
New researchco-led by The Hospital for Sick Children (SickKids) and the BC Cancer Agencyoffers a simple explanation as to why new and experimental treatments fail for children withrecurrent medulloblastoma,the most common cancerous brain tumour in children. Thestudy, part of the Medulloblastoma Advanced Genomics International Consortium (MAGIC) project, is published in the January 13 online edition of Nature.